A immunohistochemical analysis of a rat model of proliferative vitreoretinopathy and a comparison of the expression of TGF-β and PDGF among the induction methods

Bosnian Journal of Basic Medical Sciences

Volumn 10, Issue 3, 2010, Pages 204-209

  Zheng, Xiao Zhi ^a   Du, Lian Fang ^b   Wang, Hui Ping ^b  

^a NANTONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Immunohistochemistry; Induction methods; PDGF; Proliferative vitreoretinopathy; TGF 2

Indexed keywords

EID: 77957163116     PISSN: 15128601     EISSN: None     Source Type: Journal    
DOI: 10.17305/bjbms.2010.2686     Document Type: Article

References (14)

1. Agrawal R.N., He S., Spee C., Cui J.Z., Ryan S.J., Hinton D.R. In vivo models of proliferative vitreoretinopathy. Nat. Protoc. 2007; 2: 67-77.
2. Zheng X.Z., Li H.L., Du L.F., Gu Q.,Wang H.P.A rat model of proliferative vitreoretinopathy induced by RPE-J cells and platelet-rich plasma. Asian. Biomed. 2009; 3(5): 507-515.
3. Zheng X.Z., Li H.L., Du L.F., Wang H.P., Gu Q. Comparative analysis of gene transfer to human and rat retinal pigment epithelium cell line by a combinatorial use of recombinant adeno-associated virus and ultrasound or/and microbubbles. Bosnian. J. Basic. Med. 2009;9:174-181.
4. Zheng X.Z., Li H.L., Du L.F., Wang H.P., Gu Q. In vivo and in vitro effects of ultrasound or/and microbubbles on recombinant adeno-associated virus-mediated transgene expression in the retina. Asian Biomed, 2009,3(5):497-506.
5. Rao R.D., Gourab K., Bagaria V.B., Shidham V.B., Metkar U., Cooley B.C. The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein. J. Bone. Joint. Surg. Am. 2009; 91:1199-206.
6. 2 with a lower dose of adenovirus. Vision. Res. 2008; 48:1648-1654.
7. Charteris D.G. Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br. J. Ophthalmol. 1995,79:953-960.
8. Thompson, J.T. Proliferative vitreoretinopathy in: Ryan, S.J. editors, in Retina 4th edn. Vol. 3. St. Louis: Elsevier Mosby.2006; PP:2282-2309.
9. Kilian O., Flesch I., Wenisch S., et al. Effects of platelet growth factors on human mesenchymal stem cells and human endothe-lial cells in vitro. Eur. J. Med. Res. 2004; 9: 337-344.
10. 2. J. Cell Physiol. 2005; 203: 35-43.
11. Andrews A., Balciunaite E., Leong F.L., et al. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 1999;140: 2683-689
12. Ikuno Y., Leong F.L., Kazlauskas A. Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor. Invest. Ophthalmol. Vis. Sci. 2000; 41:3107-3116
13. 2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor. Exp. Eye. Res. 2006; 83: 212.
14. Mitsuhiro M.R., Eguchi S., Yamashita H. Regulation mechanisms of retinal pigment epithelial cell migration by the TGF-β super-family. Acta. Ophthalmol. Scand. 2003; 81: 630-638.